- Home
- PMNT vs ACXP Comparison
PMNT vs ACXP Comparison
Compare PMNT & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMNT
- ACXP
- Stock Information
- Founded
- PMNT 1984
- ACXP 2017
- Country
- PMNT United Kingdom
- ACXP United States
- Employees
- PMNT N/A
- ACXP N/A
- Industry
- PMNT
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- PMNT
- ACXP Health Care
- Exchange
- PMNT NYSE
- ACXP Nasdaq
- Market Cap
- PMNT 11.2M
- ACXP 9.0M
- IPO Year
- PMNT 2024
- ACXP 2021
- Fundamental
- Price
- PMNT $1.17
- ACXP $0.36
- Analyst Decision
- PMNT Strong Buy
- ACXP Strong Buy
- Analyst Count
- PMNT 1
- ACXP 1
- Target Price
- PMNT $6.00
- ACXP $12.00
- AVG Volume (30 Days)
- PMNT 91.7K
- ACXP 235.2K
- Earning Date
- PMNT 02-14-2025
- ACXP 05-13-2025
- Dividend Yield
- PMNT N/A
- ACXP N/A
- EPS Growth
- PMNT N/A
- ACXP N/A
- EPS
- PMNT N/A
- ACXP N/A
- Revenue
- PMNT $21,307,000.00
- ACXP N/A
- Revenue This Year
- PMNT $3.91
- ACXP N/A
- Revenue Next Year
- PMNT $29.32
- ACXP N/A
- P/E Ratio
- PMNT N/A
- ACXP N/A
- Revenue Growth
- PMNT N/A
- ACXP N/A
- 52 Week Low
- PMNT $0.66
- ACXP $0.35
- 52 Week High
- PMNT $3.55
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- PMNT N/A
- ACXP 26.25
- Support Level
- PMNT N/A
- ACXP $0.40
- Resistance Level
- PMNT N/A
- ACXP $0.45
- Average True Range (ATR)
- PMNT 0.00
- ACXP 0.03
- MACD
- PMNT 0.00
- ACXP 0.00
- Stochastic Oscillator
- PMNT 0.00
- ACXP 6.21
About PMNT PERFECT MOMENT LTD
Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear. It operates at the intersection of luxury fashion and multi-channel commerce. Although the Company is organized fundamentally as one business segment which is product sales, the Company's revenues are primarily split between three geographic areas which are the U. S., Europe, and the UK.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.